|
Wang, L; Radic, M Z; Galili, U (1995) Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations. J Immunol 155:1276-85
|
|
Wang, L; Anaraki, F; Henion, T R et al. (1995) Variations in activity of the human natural anti-Gal antibody in young and elderly populations. J Gerontol A Biol Sci Med Sci 50:M227-33
|
|
Hamadeh, R M; Galili, U; Zhou, P et al. (1995) Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. Clin Diagn Lab Immunol 2:125-31
|
|
Repik, P M; Strizki, J M; Galili, U (1994) Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model. J Gen Virol 75 ( Pt 5):1177-81
|
|
Winand, R J; Devigne, J W; Meurisse, M et al. (1994) Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum. J Immunol 153:1386-95
|
|
Henion, T R; Macher, B A; Anaraki, F et al. (1994) Defining the minimal size of catalytically active primate alpha 1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzyme. Glycobiology 4:193-201
|
|
Galili, U (1993) Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 14:480-2
|
|
Winand, R J; Anaraki, F; Etienne-Decerf, J et al. (1993) Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells. J Immunol 151:3923-34
|
|
Galili, U (1993) Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol 15:155-71
|
|
Galili, U; Anaraki, F; Thall, A et al. (1993) One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 82:2485-93
|
Showing the most recent 10 out of 29 publications
